Prevnar 20 2.2 ug/.5mL

Prevnar 20 is a pneumococcal 20-valent conjugate vaccine designed to help prevent pneumococcal disease. This intramuscular injection is formulated to support immune response against 20 serotypes of Streptococcus pneumoniae.

Prevnar 20 is used to help protect against pneumococcal disease, which can cause serious infections like pneumonia, meningitis, and bloodstream infections. It is typically administered to individuals who are at higher risk of contracting these infections, including young children and adults with certain medical conditions.

Common effects of Prevnar 20 may include redness, swelling, or pain at the injection site. Some individuals might experience mild fever, fatigue, or muscle aches following vaccination. These effects are generally temporary and resolve on their own.

Prevnar 20 should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or allergies before receiving the vaccine.

Prevnar 20 may interact with other vaccines or medications. It is generally recommended to space out the administration of other vaccines. Always consult a healthcare provider for personalized advice regarding potential interactions.